Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Current Deferred Revenue (2014 - 2026)

Updated

Kyntra Bio (KYNB) posted Current Deferred Revenue of $5.42 million for Q2 2026, down 80.2% from $27.31 million a year earlier and down 4.6% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Current Deferred Revenue (2014 - 2026) Analysis & Trends

At the end of FY2025, Kyntra Bio's Current Deferred Revenue came in at $5.31 million, down 80.5% from FY2024.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
  • In prior years, Kyntra Bio's Current Deferred Revenue was $27.29 million in FY2024 (+114.2%), $12.74 million in FY2023 (unchanged), $12.74 million in FY2022 (-19.7%) and $15.86 million in FY2021 (+142.2%).
  • Quarterly Current Deferred Revenue has run from a low of $4.74 million in Q1 2022 to a high of $28.86 million in Q3 2024 over five years.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with growth averaging 43.9% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2024, with growth of 294.0%; the weakest was Q3 2025, with a decline of 82.3%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $5.68 million (Q1 2026), $5.31 million (Q4 2025) and $5.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kyntra Bio 21.25 Mn -386.69 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.42 Mn
Mar 31, 2026 5.68 Mn
Dec 31, 2025 5.31 Mn
Sep 30, 2025 5.10 Mn
Jun 30, 2025 27.31 Mn
Mar 31, 2025 22.51 Mn
Dec 31, 2024 27.29 Mn
Sep 30, 2024 28.86 Mn
Jun 30, 2024 9.55 Mn
Mar 31, 2024 12.86 Mn
Dec 31, 2023 12.74 Mn
Sep 30, 2023 7.33 Mn
Jun 30, 2023 7.49 Mn
Mar 31, 2023 16.50 Mn
Dec 31, 2022 12.74 Mn
Sep 30, 2022 7.36 Mn
Jun 30, 2022 6.90 Mn
Mar 31, 2022 4.74 Mn
Dec 31, 2021 15.86 Mn
Sep 30, 2021 23.26 Mn
API Access

Kyntra Bio Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KYNB&period=max&api_key=YOUR_API_KEY